Our Annual Fall Clinical Dermatology Conference is framed to improve our attendees' value and clinical skills through a uniquely designed educational experience. Check back here as we highlight key sessions and posters during the conference!
Looking to register for Fall Clinical 2025? Click HERE
In this session, James Del Rosso, DO, and Karan Lal, DO, provided insights into management of patients with acne.
The presentation started with emphasis on patient-centered and collaborative...
Read more
In this session, Brian Berman, MD, PhD, and Darrell Rigel, MD, MS, provided an overview of available therapies for actinic keratoses (AKs), emphasizing combination therapies and delivering individualized...
Read more
Dr Alexandra Golant provided an overview of the evolving landscape of atopic dermatitis (AD) treatment, focusing on new insights into AD pathogenesis and therapeutic advancements that are reshaping...
Read more
Andrew Alexis, MD, MPH, provides an overview of hyperpigmentation and available treatments for patients. Melasma is subcategorized into centrofacial, malar, and mandibular based on primary facial location as...
Read more
Dr Tejesh Patel presented on the pathogenesis of itch in prurigo nodularis (PN) and atopic dermatitis (AD), emphasizing the underlying mechanisms that contribute to these conditions. He explored...
Read more
Authors: Maryanne Senna, Susan Taylor, Bianca Piraccini, Jerry Shapiro, Najwa Somani, Jakub Jedynak, Samuel Ogwu, Andrew Buchanan, Brittany Craiglow, Manabu Ohyama
Baricitinib is a systemic therapy FDA approved...
Read more
In this comprehensive 5-part lecture, Linda F. Stein Gold, MD, April W. Armstrong, MD, MPH, Boni E. Elewski, MD, Dirk M. Elston, MD, and Theodore Rosen, MD, provided...
Read more
Brad P. Glick, DO, MPH, David Lang, MD, and Dawn L. Merritt, DO, provided insights into chronic spontaneous urticaria (CSU). The conversation alternated between dermatology and allergist perspectives...
Read more
This presentation by James Q. Del Rosso, DO, focused on recent findings in dermatologic therapies. Starting with dupilumab, a study reported that dupilumab can be an effective treatment...
Read more
Tasneem F. Mohammad, MD, delved into the current state of photoprotection, highlighting key advances and challenges in protecting the skin from harmful radiation. The presentation outlines various methods...
Read more
Authors: Alexis Ogdle et al.
The FORWARD Psoriasis Registry was developed to collect and analyze the demographics, disease characteristics, and treatments among patients with psoriasis (PsO). The aim...
Read more
This 4-part lecture series built on “What Did 2024 Bring to the Table in Dermatology – Part 1” and provided even more updates on dermatology advancements. Dr Lisa...
Read more
The "Topical Therapy Forum" lecture series presented an in-depth look at advancements in topical treatments across several dermatologic conditions, with each expert delving into the latest innovations and...
Read more
The presentation on the comorbidities of psoriasis, led by Drs Bruce E. Strober, Joel M. Gelfand, and Karan Lal, highlighted the significant health risks associated with psoriasis. The...
Read more
This session explores the latest clinical evidence on the efficacy and safety of oral JAK inhibitors for managing alopecia areata (AA), including criteria for patient selection, dose adjustment...
Read more
Authors: A. McMichael et al.
This poster presents data from the Phase 3b VISIBLE study, a multicenter, randomized, double-blind, placebo-controlled trial evaluating guselkumab (GUS) in participants with moderate-to-severe...
Read more
Dr April W. Armstrong’s presentation highlighted a series of impactful recent studies, covering a broad range of dermatologic conditions and treatments, published in JAMA Dermatology. She begins...
Read more
Dr Dirk Elston presented a comprehensive review of the top JAAD articles and findings from 2024. Dr Elston truly highlighted the major impact of JAAD with a presentation...
Read more
Dr Roger Ceilley provided a comprehensive overview of the past year for SKIN: The Journal of Cutaneous Medicine, highlighting the journal’s rapid growth and valuable contributions to...
Read more
Dr Marc D. Brown’s presentation provided a detailed overview of recent studies shaping dermatologic surgery practices published in Dermatologic Surgery. One key topic addressed in the journal...
Read more
Author: Neil J. Korman et al.
Deucravacitinib, an oral TYK2 inhibitor, is FDA approved for the systemic treatment of moderate-to-severe plaque psoriasis. This poster presents updated four-year data...
Read more
Author: April W. Armstrong et al.
Deucravacitinib, an oral TYK2 inhibitor, is FDA approved for the systemic treatment of moderate-to-severe plaque psoriasis. This poster presents updated four-year safety...
Read more

Brooke Bartley, MD
Internal Medicine Preliminary Resident
Texas Health Presbyterian Dallas
Read more